REG - Glenveagh Properties - Total Voting Rights

Glenveagh PropertiesAnnouncement

01/03/2024 09:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240301:nRSA2587Fa&default-theme=true

RNS Number : 2587F  Glenveagh Properties plc  01 March 2024

01 March 2024

 

Glenveagh Properties plc

Total Voting Rights

Dublin/London, 01 March 2024: In conformity with Regulation 20 of the
Transparency (Directive 2004/109/EC) Regulations 2007, Glenveagh Properties
plc (the "Company") announces that:

As at 29 February 2024, the Company's share capital consists of 578,049,118
Ordinary Shares of nominal value €0.001 each.  The Company does not hold
any Ordinary Shares in treasury. Therefore, the total number of voting rights
in the Company is 578,049,118.

The above figure may be used by shareholders as a denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the
Transparency (Directive 2004/109/EC) Regulations 2007.

 

For further information please contact:

Chloe McCarthy

Group Company Secretary

chloe.mccarthy@glenveagh.ie

 

 

 

Note to Editors

Glenveagh Properties plc, listed on Euronext Dublin and the London Stock
Exchange, is a leading Irish homebuilder.

Supported by innovation and supply chain integration, Glenveagh are committed
to opening up access to sustainable high-quality homes to as many people as
possible in flourishing communities across Ireland.

We are focused on three core markets - suburban housing, urban apartments and
partnerships with local authorities and state agencies. The landbank we have
assembled can deliver housing that is both in demand and affordable.

www.glenveagh.ie (http://www.glenveagh.ie)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVREANDFEASLEEA